173 related articles for article (PubMed ID: 21763750)
1. The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology.
Caburet S; Georges A; L'Hôte D; Todeschini AL; Benayoun BA; Veitia RA
Mol Cell Endocrinol; 2012 Jun; 356(1-2):55-64. PubMed ID: 21763750
[TBL] [Abstract][Full Text] [Related]
2. The mutations and potential targets of the forkhead transcription factor FOXL2.
Moumné L; Batista F; Benayoun BA; Nallathambi J; Fellous M; Sundaresan P; Veitia RA
Mol Cell Endocrinol; 2008 Jan; 282(1-2):2-11. PubMed ID: 18155828
[TBL] [Abstract][Full Text] [Related]
3. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
[TBL] [Abstract][Full Text] [Related]
4. Foxl2 function in ovarian development.
Uhlenhaut NH; Treier M
Mol Genet Metab; 2006 Jul; 88(3):225-34. PubMed ID: 16647286
[TBL] [Abstract][Full Text] [Related]
5. FOXL2: a central transcription factor of the ovary.
Georges A; Auguste A; Bessière L; Vanet A; Todeschini AL; Veitia RA
J Mol Endocrinol; 2014 Feb; 52(1):R17-33. PubMed ID: 24049064
[TBL] [Abstract][Full Text] [Related]
6. Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.
De Baere E; Copelli S; Caburet S; Laissue P; Beysen D; Christin-Maitre S; Bouchard P; Veitia R; Fellous M
Pediatr Endocrinol Rev; 2005 Jun; 2(4):653-60. PubMed ID: 16208278
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
[TBL] [Abstract][Full Text] [Related]
8. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
[TBL] [Abstract][Full Text] [Related]
9. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.
Batista F; Vaiman D; Dausset J; Fellous M; Veitia RA
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3330-5. PubMed ID: 17360647
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase.
Benayoun BA; Georges AB; L'Hôte D; Andersson N; Dipietromaria A; Todeschini AL; Caburet S; Bazin C; Anttonen M; Veitia RA
Hum Mol Genet; 2011 May; 20(9):1673-86. PubMed ID: 21289058
[TBL] [Abstract][Full Text] [Related]
11. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case Report.
Méduri G; Bachelot A; Duflos C; Bständig B; Poirot C; Genestie C; Veitia R; De Baere E; Touraine P
Hum Reprod; 2010 Jan; 25(1):235-43. PubMed ID: 19819892
[TBL] [Abstract][Full Text] [Related]
12. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
Kim JH; Bae J
J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2.
Laissue P; Lakhal B; Benayoun BA; Dipietromaria A; Braham R; Elghezal H; Philibert P; Saâd A; Sultan C; Fellous M; Veitia RA
J Med Genet; 2009 Jul; 46(7):455-7. PubMed ID: 19429596
[TBL] [Abstract][Full Text] [Related]
14. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
Fan JY; Han B; Qiao J; Liu BL; Ji YR; Ge SF; Song HD; Fan XQ
Mutagenesis; 2011 Mar; 26(2):283-9. PubMed ID: 21068205
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Tang S; Wang X; Lin L; Sun Y; Wang Y; Yu H
Mutagenesis; 2006 Jan; 21(1):35-9. PubMed ID: 16394030
[TBL] [Abstract][Full Text] [Related]
16. The human FOXL2 mutation database.
Beysen D; Vandesompele J; Messiaen L; De Paepe A; De Baere E
Hum Mutat; 2004 Sep; 24(3):189-93. PubMed ID: 15300845
[TBL] [Abstract][Full Text] [Related]
17. FOXL2: at the crossroads of female sex determination and ovarian function.
Benayoun BA; Dipietromaria A; Bazin C; Veitia RA
Adv Exp Med Biol; 2009; 665():207-26. PubMed ID: 20429427
[TBL] [Abstract][Full Text] [Related]
18. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients.
Nallathambi J; Laissue P; Batista F; Benayoun BA; Lesaffre C; Moumné L; Pandaranayaka PE; Usha K; Krishnaswamy S; Sundaresan P; Veitia RA
Hum Mutat; 2008 Aug; 29(8):E123-31. PubMed ID: 18484667
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
[TBL] [Abstract][Full Text] [Related]
20. Blepharophimosis-ptosis-epicanthus inversus syndrome in a girl with chromosome translocation t(2;3)(q33;q23).
Tzschach A; Kelbova C; Weidensee S; Peters H; Ropers HH; Ullmann R; Erdogan F; Jurkatis J; Menzel C; Kalscheuer V; Demuth S
Ophthalmic Genet; 2008 Mar; 29(1):37-40. PubMed ID: 18363172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
